AdvaMedDx Valid Act of 2021 Webinar

This report outlines a key data-driven summary of the U.S. COVID testing supply.

Today, the Advanced Medical Technology Association (AdvaMed) released the following statement from President and CEO Scott Whitaker following the Department of Health and Human Services’ announcement regarding new requirements for laboratory-developed tests (LDTs):

Participate in this letter writing campaign to further ongoing advocacy efforts to improve and advance The VALID Act, comprehensive diagnostics regulatory reform legislation.

AdvaMed released the following statement from AdvaMedDx Executive Director Susan Van Meter on the testing policy regulation recently proposed by the Occupational Safety and Health Administration (OSHA) for employers with 100 or more employees under the Administration’s vaccine mandate:

The Advanced Medical Technology Association (AdvaMed) has launched the AdvaMed Code of Ethics on interactions with health care professionals in India. It provides medical technology and diagnostics makers with compliance principles and guidance that addresses key legal risk areas that govern business relationships and activities.

AdvaMedDx cohosted a briefing session with the CDC Mycotic Diseases Branch on their current work in the mycotic disease space.

The MedTech Conference, the Advanced Medical Technology Association’s (AdvaMed) premier annual gathering, wrapped up Thursday following four days of networking opportunities, presentations and panel discussions on the top issues facing the medical technology industry and health care.

AdvaMed today announced that former Becton Dickinson (BD) CEO Edward J. Ludwig will receive the 2021 AdvaMed Lifetime Achievement Award, sponsored by IQVIA, at the industry’s premier annual gathering, The MedTech Conference 2021.